Open-framework structures of transition-metal compounds

Inorganic framework solids are no longer limited to just the silicates and phosphates. Recent research has revealed that carboxylates, arsenates, sulfates, selenates, selenites, germanates, phosphites can also form such structures. One of the emerging areas combines the rich coordination chemistry of the central metal ions of many of these structures with the flexibility and functionality of the organic linkers to give rise to organic-inorganic hybrid compounds. The compounds of the transition-metals appear to provide many variations arising from their coordination preferences, ligand geometry, and the valence state. In addition, the combination of the magnetic nature of the transition metal center with the channel structure of open frameworks suggests interesting potential applications. In this Review the synthesis, structures and properties of the various transition-metal open-framework compounds are discussed.     

Ruthenium catalyzed hydroboration of terminal alkynes to z-vinylboronates

The nonclassical ruthenium hydride pincer complex [Ru(PNP)(H)(2)(H(2))] 1 (PNP = 1,3-bis(di-tert-butyl-phosphinomethyl)pyridine) catalyzes the anti-Markovnikov addition of pinacolborane to terminal alkynes yielding Z-vinylboronates at mild conditions. The complex [Ru(PNP)(H)(2)(HBpin)] 2 (HBpin = pinacolborane), which was identified at the end of the reaction and prepared independently, is proposed as the direct precursor to the catalytic cycle involving rearrangement of coordinated alkyne to Z-vinylidene as a key step for the apparent trans-hydroboration.     

Existence of a new emitting singlet state of proflavine: femtosecond dynamics of the excited state processes and quantum chemical studies in different solvents

Proflavine (3,6-diaminoacridine) shows fluorescence emission with lifetime, 4.6 ± 0.2 ns, in all the solvents irrespective of the solvent polarity. To understand this unusual photophysical property, investigations were carried out using steady state and time-resolved fluorescence spectroscopy in the pico- and femtosecond time domain. Molecular geometries in the ground and low-lying excited states of proflavine were examined by complete structural optimization using ab initio quantum chemical computations at HF/6-311++G** and CIS/6-311++G** levels. Time dependent density functional theory (TDDFT) calculations were performed to study the excitation energies in the low-lying excited states. The steady state absorption and emission spectral details of proflavine are found to be influenced by solvents. The femtosecond fluorescence decay of the proflavine in all the solvents follows triexponential function with two ultrafast decay components (τ(1) and τ(2)) in addition to the nanosecond component. The ultrafast decay component, τ(1), is attributed to the solvation dynamics of the particular solvent used. The second ultrafast decay component, τ(2), is found to vary from 50 to 215 ps depending upon the solvent. The amplitudes of the ultrafast decay components vary with the wavelength and show time dependent spectral shift in the emission maximum. The observation is interpreted that the time dependent spectral shift is not only due to solvation dynamics but also due to the existence of more than one emitting state of proflavine in the solvent used. Time resolved area normalized emission spectral (TRANES) analysis shows an isoemissive point, indicating the presence of two emitting states in homogeneous solution. Detailed femtosecond fluorescence decay analysis allows us to isolate the two independent emitting components of the close lying singlet states. The CIS and TDDFT calculations also support the existence of the close lying emitting states. The near constant lifetime observed for proflavine in different solvents is suggested to be due to the similar dipole moments of the ground and the evolved emitting singlet state of the dye from the Franck-Condon excited state.     

A study of the thermal properties of single jersey fabrics of cotton, bamboo and cotton/bamboo blended-yarn vis-a-vis bamboo fibre presence and yarn count

In this study, the thermal properties of 100% cotton, 50/50 cotton/bamboo and 100% bamboo single jersey fabrics with differing yarn linear density are evaluated and analysed. The linear densities of the yarns composing the fabrics are 20^s, 25^s, 30^s Ne_c and the twist level in the yarns is kept the same. An increasing the presence of bamboo fibre in the fabric causes a reduction in fabric thickness and GSM for all linear densities of yarn. Air permeability and water-vapour permeability also increase with increase in bamboo fibre content while both thermal conductivity and thermal resistance show a decreasing trend. As the constituent yarn gets finer, fabric air and water-vapour permeability both increase in value while the thermal conductivity falls.     

Development of a urea-adduct process for recovery of n-alkane based diluent from spent PUREX/UREX solvent

Urea-adduct process is commercially used to selectively separate n-alkanes from industrial hydrocarbon mixtures. Authors have explored application of this method for recovery of n-alkane based diluents from spent PUREX/UREX solvent. Traditionally this separation is performed by vacuum distillation, an energy-intensive process. The proposed method is simple and does not involve either exotic chemicals or complex processing steps. Application of urea-adduct process for recovery of diluent from spent solvent is reported here possibly first time in literature. Physical properties such as densities, viscosities and vapour pressure for irradiated organic solutions were also measured and reported.     

In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design,Development and Therapy

Parkinson’s disease (PD) and Alzheimer’s disease (AD) are neurodegenerative disorders that have emerged as among the serious health problems of the 21st century. The medications currently available to treat AD and PD have limited efficacy and are associated with side effects. Natural products are one of the most vital and conservative sources of medicines for treating neurological problems. Karanjin is a furanoflavonoid, isolated mainly from Pongamia pinnata with several medicinal plants, and has been reported for numerous health benefits. However, the effect of karanjin on AD and PD has not yet been systematically investigated. To evaluate the neuroprotective effect of karanjin, extensive in silico studies starting with molecular docking against five putative targets for AD and four targets for PD were conducted. The findings were compared with three standard drugs using Auto Dock 4.1 and Molegro Virtual Docker software. Additionally, the physiochemical properties (Lipinski rule of five), drug-likeness and parameters including absorption, distribution, metabolism, elimination and toxicity (ADMET) profiles of karanjin were also studied. The molecular dynamics (MD) simulations were performed with two selective karanjin docking complexes to analyze the dynamic behaviors and binding free energy at 100 ns time scale. In addition, frontier molecular orbitals (FMOs) and density-functional theory (DFT) were also investigated from computational quantum mechanism perspectives using the Avogadro-ORCA 1.2.0 platform. Karanjin complies with all five of Lipinski’s drug-likeness rules with suitable ADMET profiles for therapeutic use. The docking scores (kcal/mol) showed comparatively higher potency against AD and PD associated targets than currently used standard drugs. Overall, the potential binding affinity from molecular docking, static thermodynamics feature from MD-simulation and other multiparametric drug-ability profiles suggest that karanjin could be considered as a suitable therapeutic lead for AD and PD treatment. Furthermore, the present results were strongly correlated with the earlier study on karanjin in an Alzheimer’s animal model. However, necessary in vivo studies, clinical trials, bioavailability, permeability and safe dose administration, etc. must be required to use karanjin as a potential drug against AD and PD treatment, where the in silico results are more helpful to accelerate the drug development.